Peer-reviewedCC BYCancers
Re-Evaluating Multi-Kinase Inhibitors Targeting FGFR and VEGFR Pathways for Combined Therapy in Colorectal Cancer: A Preclinical Study
4 affiliations
- 1Department of Pathology, Kazan State Medical University, Kazan 420012, Russia; (T.G.); (P.D.); (A.G.); (A.G.)
- 2Central Research Laboratory, Kazan State Medical University, Kazan 420012, Russia;
- 3Division of Translational Oncology, N.N. Blokhin National Medical Research Center of Oncology, Moscow 115478, Russia;
- 4Department of Pathological Physiology, Sechenov First Moscow State Medical University, Moscow 119019, Russia;
Related
- Antibody-drug conjugate combination therapy targeting LGR5 and MET with different payloads enhances efficacy in preclinical colorectal cancer models
- Targeting tankyrase scaffolding in the β-catenin destruction complex by PROTAC overcomes the limitation of catalytic inhibitors in colorectal cancer
- 618 A novel preclinical mouse model to investigate IL-18-targeting therapies
- 882 BCG040, a novel B7-H4-targeting biparatopic ADC, demonstrates superior preclinical efficacy in heterogeneous tumors
- 401 genO-hCCR8/hCCL1/hFcγR preclinical mouse model for efficacy assessment of CCR8-targeting agents
BibTeX
@article{boichuk2026reevaluating,
title = {{Re-Evaluating Multi-Kinase Inhibitors Targeting FGFR and VEGFR Pathways for Combined Therapy in Colorectal Cancer: A Preclinical Study}},
author = {Sergei Boichuk and Tatyana Gessel and Pavel Dunaev and Alina Galyautdinova and Emiliya S. Egorova and Pavel B. Kopnin and Natalya Andriutsa and Aigul Galembikova},
journal = {Cancers},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13664539},
note = {CC BY},
}
RIS
TY - JOUR
TI - Re-Evaluating Multi-Kinase Inhibitors Targeting FGFR and VEGFR Pathways for Combined Therapy in Colorectal Cancer: A Preclinical Study
AU - Sergei Boichuk
AU - Tatyana Gessel
AU - Pavel Dunaev
AU - Alina Galyautdinova
AU - Emiliya S. Egorova
AU - Pavel B. Kopnin
AU - Natalya Andriutsa
AU - Aigul Galembikova
PY - 2026
DA - 2026/09/22
JO - Cancers
UR - https://europepmc.org/article/PMC/PMC13664539
SN - 2072-6694
ER -